This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Vaccines Market

Vaccines Market Analysis by Technology (Conjugate Vaccines, Inactivated & Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Viral Vector Vaccines), Type (Monovalent Vaccines and Multivalent Vaccines) & Region - Forecast to 2022-2032

Market Insights on Vaccines covering sales outlook, demand forecast & up-to-date key trends

Vaccines Market Outlook 2022-2032

[332 Pages Report] During the assessment period, the worldwide Vaccines Market Growth is predicted to rise at a robust CAGR of 10% from US$ 42 Bn in 2021 to US$ 120 Bn by 2032.

"Increasing public awareness of vaccination and government support in R&D are driving the market growth."

The rising supply of items to meet patient needs will grow the vaccine market. Increasing unmet needs and the worldwide goal to eliminate endemic illnesses will spur vaccine development. Pharmaceutical corporations, government foundations, international organisations, and hospitals work together to develop affordable vaccinations and immunisation regimens

The government is expected to actively monitor the vaccines market growth at low or no cost to individuals in the future years. Companies' increased R&D expenditure for new items will increase vaccine market demand, benefiting the market.

Attributes

Details

Vaccines Market CAGR (2022 – 2032)

10%

Vaccines Market (2032)

US$ 120 Bn

Vaccines Market Attraction

Advanced technology and cost efficiency are increasing the vaccines market growth.

What is the Impact of COVID-19 on the Vaccines Market?

The outbreak of Covid-19 brought ample opportunities for the vaccine manufacturing companies to develop vaccines for preventing coronavirus infections. Some of them succeeded in finding different types of Covid-19 vaccine to prevent the spread.

These companies experienced some negative impacts during this period also. For instance, the complete focus of healthcare resources of every country was diverted towards meeting the challenge of rising infection cases side-lining the services provided for patients of other diseases.

As vaccination programmes to prevent other diseases were not possible, vaccine booking dropped down significantly, severely hampering manufacturing companies' business.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Dynamics of the Vaccines Market?

"Huge capital investments and low purchasing power in emerging markets may impede market development."

With humans travelling at a much higher rate and covering much greater distances than in the past, living in densely inhabited places, and coming into closer touch with wild animals, the potential for new infectious illnesses to spread swiftly and trigger worldwide epidemics is a big concern. 

The vaccines market will continue to propel because illnesses may evolve due to terrorists' purposeful introduction into human, animal, or plant populations. Around 40 infectious illnesses have been found since the 1970s, including SARS, MERS, Ebola, chikungunya, and Zika, which is caused by a novel coronavirus, SARS-CoV-2. 

Experts have predicted that future pandemics and epidemics would be deadlier than COVID-19. The increasing incidence of these infectious illnesses will ensure that demand for vaccines adoption trends continues to increase in the future years. 

Additionally, the introduction of new illnesses will result in increased R&D spending, a robust pipeline, and new vaccines market opportunities for broad population sectors.

What are the Roadblocks to Expansion for Vaccines Market Players?

Vaccines development is a costly endeavour. The development process takes 10–15 years (from in vitro research to commercialisation) and involves an expenditure of Billion dollars. Vaccines research has a poor success rate; firms face difficulty securing early financing and managing operating costs. 

Vaccines have more excellent storage and distribution cost than any other pharmaceutical medication, as they require specific infrastructure and monitoring systems. Inadequate storage and distribution facilities might result in a deterioration of vaccine quality. As a result, the high expense of developing and storing is impeding the expansion of the vaccines market.

What are the Most Important Trends and Opportunities for Vaccines Market?

Due to their large patient populations and rising disposable incomes, emerging regions such as India, China, and Southeast Asia represent the exciting potential for the vaccines market business. This development potential has attracted the attention of prominent market participants who have invested in these economies. 

Numerous organisations and institutions, such as GAVI, are actively promoting vaccines market usage in impoverished countries, for example, by distributing vaccines at a cheap cost. As a result, these nations have emerged as crucial growth hotspots in the vaccines industry. 

Another trend in emerging economies is an increase in demand for affordable vaccines. Businesses are investing in and concentrating their efforts on developing inexpensive, low-cost vaccines to expand the reach of immunisation programmes in these economies.

Which are the Threats Faced by Players in the Vaccines Market?

This is a critical issue in the industry, particularly in impoverished places where awareness campaigns and efforts have failed to penetrate adequately or entirely. Vaccines may also be unavailable in some instances, such as distant places, due to a lack of adequate storage facilities and government backing. 

Other obstacles, such as poor literacy rates, a lack of health education, and financial constraints, have also hampered vaccines market access.

Comparative View of Adjacent Vaccines Market

Vaccines Market :

Attributes

Vaccines Market

CAGR (2022 - 2032)

10%

Market Value (2026)

US$ 67 Bn

Growth Factor

Increasing focus on immunization of the populace to underpin growth.

Opportunity

Investments from governments to support vaccine development.

Key Trends

Development of vaccines with low response time to get better exposure.

Veterinary Vaccines Market :

Attributes

Veterinary Vaccines Market

CAGR (2022 - 2032)

7%

Market Value (2026)

US$ 12 Bn

Growth Factor

Demand for animal-based plant product generates high adoption of veterinary vaccines.

Opportunity

Increasing initiatives taken by governments to improve animal health creates opportunity for market players.

Key Trends

Rising focus on technological innovations to offer opportunities.

COVID-19 Vaccines Market :

Attributes

COVID-19 Vaccines Market

CAGR (2022 - 2032)

-15%

Market Value (2026)

US$ 1.4 Bn

Growth Factor

Rising investments towards COVID-19 vaccine development to drive significant growth.

Opportunity

Increasing focus on improving the efficiency of COVID-19 vaccines.

Key Trends

Investment towards R&D activities to underpin opportunities.

Vaccine technology has evolved rapidly in the last decade, profoundly influencing the vaccines market future trends. The introduction of genetic engineering has fuelled many advances in vaccine development programmes and vaccine market structure, resulting in new products and the development of several virus vaccines that use an attenuated form of the virus, augmenting the overall vaccine industry profits.

Most of the vaccines market key trends & opportunities have been primarily driven by the need to shorten response times towards emerging threats and make possible vaccines market access to rapid deployment. Several vaccine market companies have shifted their focus to this aspect to scale up their market share.

The steadily rising necessity to develop the best vaccine against challenging targets and improve delivery systems for maximum potency also drives the demand for vaccine innovation. A few of the technological innovations among the recent developments in the vaccines market are the evolution of synthetic vaccine candidates, vaccine response, structure-based antigen design, and genomic analysis of disease progression, which effectively enhances the global vaccine market size.

As a result, technological advancements are expected to drive the development of new and more effective vaccines for a variety of new indications as well as surge vaccine industry profits, thereby propelling the vaccines market growth.

The vaccines market value is likely to expand positively as investments in research and development increase against various diseases. Furthermore, potential product launches are expected to enlarge the vaccines market size during the forecast period. 

Several potential vaccine candidates in the global vaccine market, for example, are in the pipelines of pharmaceutical companies such as Pfizer, Johnson & Johnson, and others, thereby making a wide array of vaccines market opportunities available.

Scientists have begun to use artificial intelligence to sort and analyse potential vaccine development approaches far more quickly than any human team could through informed trial-and-error. This is expected to shape the vaccine market trends to a considerable level.

AI has the potential to improve the speed at which potential candidates are evaluated as technology advances, and this most likely resolves the issue involved in the vaccine market in the world, such as sifting through thousands of potential compounds to gauge the viability of the same by scientists which are considered to be one of the crucial emerging trends in the vaccines market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which are the Key Segments in the Vaccines Market?

By 2020, the conjugate vaccines segment accounted for the largest share of the global vaccine market by technology type under increased government spending and investment by companies on its development. The other technologies, such as inactivated, live attenuated, and recombinant vaccines, are also gaining demand and are predicted to occupy a substantial market share during the forecast period.

What are the Different Disease Indications in the Vaccines Market?

Different types of vaccines are developed and categorized based on the diseases used. Though Influenza diseases are the most widespread across all regions, indications of pneumococcal diseases account for the largest segment against all other disease indications.

The Indication of other diseases such as combination vaccines meningococcal disease are also growing in number in the contemporary world and are expected to increase the total volume of supply for vaccines.

Which Segment of End users are the Significant Contributors to the Vaccine Market?

Vaccines are developed to be used in both children and adults. The paediatric vaccines segment contributed a significant share of the global vaccine market, while the vaccine segment for adults will increase after the Covid-19 pandemic all over the world.

What are the Different Methods of Administration in the Vaccine Market?

Among all the routes of administration by which the vaccine market is categorized, Intramuscular and subcutaneous routes are the most preferred method by all healthcare professionals globally.

Oral and other routes of administration are also getting popular in the aftermath of the Covid-19 pandemic to increase the supply of contactless vaccine administration.

Why is North America the Leading Vaccines Market?

As most of the key players are present in North America, it is the largest market in all categories and will continue to grow faster than any other region of the world.

Along with the medical uses, pet vaccination is also a growing industry in developed regions. Vaccines for various animals, particularly dog vaccines, are in greater demand in North America and adjacent areas.

Government spending for immunization programs in the Asia Pacific region and African countries has positioned these parts of the world as lucrative markets for vaccine manufacturers. Increased awareness among people about vaccines and the developing healthcare sector that provides vaccine certificates has also increased the demand for vaccines at the individual level.

Moreover, the higher investment of public money and new business start-ups in the research and development of new vaccines poses a severe challenge to previously established players in the global vaccine market, as reported by some vaccine journals. Also, due to the massive population in the countries of these regions, the vaccine market is the primary focus of all the major players.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

How Intense is the Competition in the Vaccines Market?

Major players that are leading the vaccine market by research, development, production and distribution are Merck & Co., Inc; Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson & Johnson (J&J), AstraZeneca plc, Bavarian Nordic A/S, and Mitsubishi Tanabe Pharma Corporation. 

GSK, Pfizer, Mark and Sanofi are the largest manufacturers of vaccines controlling about 90% of the vaccine supply by volume. Manufacturers in Asia also increase their production capacity and are categorized under mid-size manufacturers. 

Recent Developments in the Vaccines Market:

  • VAXELIS, a combination of diphtheria toxoids, tetanus toxoids, acellular pertussis, inactive poliovirus, Haemophilus b conjugate, and hepatitis B, was developed and launched in 2021 by Merck along with Sanofi Pasteur.
  • To control shingles or herpes zoster in adults, GSK developed a Zoster vaccine recombinant by the name of Shingrix vaccine. It received the approval of the US Food and Drug Administration (FDA) in 2021 to be used in 18 above adults who are at risk of the disease due to immunodeficiency or immunosuppression.
  • By August 2021, the vaccine for Covid-19 developed by Pfizer-BioNTech named COMIRNATY was ready. It was first approved for adults by the US FDA, and later in October 2021, it received the emergency use authorization (EUA) for children of 5 to 11 years of age.

Key Segments

By Technology:

  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Viral Vector Vaccines

By Type:

  • Monovalent Vaccines
  • Multivalent Vaccines

By Route of Administration:

  • Intramuscular & Subcutaneous Administration 
  • Oral Administration
  • Other routes (Intranasal, Intradermal and Percutaneous)

By Disease Indication:

  • Influenza
  • Pneumococcal Diseases
  • Combination Vaccines
  • HPV
  • Herpes Zoster
  • Meningococcal Diseases
  • Rotavirus
  • MMR
  • Varicella
  • Hepatitis 
  • DTP
  • Polio
  • Covid-19
  • Other Disease Indications (Cancer, Dengue, Tuberculosis, Typhoid, Japanese Encephalitis, Rabies, Yellow Fever, and Allergies)

By End User:

  • Pediatric Vaccines
  • Adult Vaccines

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

The vaccines market is expected to register a 10% CAGR during the projected period.

In 2021, the vaccines market registered a value of US$ 42 Bn.

The vaccines market growth is predicted to reach a valuation of US$ 120 Bn by 2032.

By 2026, the vaccines market is expected to cross a valuation of US$ 67 Bn.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Vaccines Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Vaccines Market By Country, US$ Mn

    4.2. Vaccines Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Vaccines Market Growth

        4.5.3. Vaccines Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Vaccines Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Vaccines Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Vaccines Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Technology

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) and Analysis By Technology, 2015-2021

    8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Technology, 2022-2032

        8.3.1. Conjugate Vaccines

        8.3.2. Inactivated & Subunit Vaccines

        8.3.3. Live Attenuated Vaccines

        8.3.4. Recombinant Vaccines

        8.3.5. Toxoid Vaccines

        8.3.6. Viral Vector Vaccines

    8.4. Market Attractiveness Analysis By Technology

9. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) and Analysis By Type, 2015-2021

    9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Type, 2022-2032

        9.3.1. Monovalent Vaccines

        9.3.2. Multivalent Vaccines

    9.4. Market Attractiveness Analysis By Type

10. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Route of Administration

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) and Analysis By Route of Administration, 2015-2021

    10.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Route of Administration, 2022-2032

        10.3.1. Intramuscular & Subcutaneous Administration

        10.3.2. Oral Administration

        10.3.3. Other Routes of Administration (Intranasal, Intradermal, and Percutaneous)

    10.4. Market Attractiveness Analysis By Route of Administration

11. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Value (US$ Mn) and Analysis By Disease Indication, 2015-2021

    11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Disease Indication, 2022-2032

        11.3.1. Influenza

        11.3.2. Pneumococcal Diseases

        11.3.3. Combination Vaccines

        11.3.4. HPV

        11.3.5. Herpes Zoster

        11.3.6. Meningococcal Diseases

        11.3.7. Rotavirus

        11.3.8. MMR

        11.3.9. Varicella

        11.3.10. Hepatitis

        11.3.11. DTP

        11.3.12. Polio

        11.3.13. COVID 19

        11.3.14. Other Disease Indications (Cancer, Dengue, Tuberculosis, Typhoid, Japanese Encephalitis, Rabies, Yellow Fever, and Allergies)

    11.4. Market Attractiveness Analysis By Disease Indication

12. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By End-user

    12.1. Introduction / Key Findings

    12.2. Historical Market Value (US$ Mn) and Analysis By End-user, 2015-2021

    12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By End-user, 2022-2032

        12.3.1. Pediatric Vaccines

        12.3.2. Adult Vaccines

    12.4. Market Attractiveness Analysis By End-user

13. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    13.1. Introduction

    13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021

    13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. Asia Pacific

        13.3.5. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Vaccines Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

        14.4.2. By Route of Administration

        14.4.3. By Technology

        14.4.4. By Type

        14.4.5. By Disease Indication

        14.4.6. By End-user

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Route of Administration

        14.5.3. By Technology

        14.5.4. By Type

        14.5.5. By Disease Indication

        14.5.6. By End-user

15. Latin America Vaccines Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Brazil

            15.4.1.2. Mexico

            15.4.1.3. Rest of Latin America

        15.4.2. By Route of Administration

        15.4.3. By Technology

        15.4.4. By Type

        15.4.5. By Disease Indication

        15.4.6. By End-user

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Route of Administration

        15.5.3. By Technology

        15.5.4. By Type

        15.5.5. By Disease Indication

        15.5.6. By End-user

16. Europe Vaccines Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. France

            16.4.1.3. U.K.

            16.4.1.4. Italy

            16.4.1.5. Russia

            16.4.1.6. Rest of Europe

        16.4.2. By Route of Administration

        16.4.3. By Technology

        16.4.4. By Type

        16.4.5. By Disease Indication

        16.4.6. By End-user

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Route of Administration

        16.5.3. By Technology

        16.5.4. By Type

        16.5.5. By Disease Indication

        16.5.6. By End-user

17. Asia Pacific Vaccines Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

            17.4.1.4. Rest of Asia Pacific

        17.4.2. By Route of Administration

        17.4.3. By Technology

        17.4.4. By Type

        17.4.5. By Disease Indication

        17.4.6. By End-user

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Route of Administration

        17.5.3. By Technology

        17.5.4. By Type

        17.5.5. By Disease Indication

        17.5.6. By End-user

18. Middle East and Africa Vaccines Market Analysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        18.4.1. By Country

            18.4.1.1. GCC Countries

            18.4.1.2. South Africa

            18.4.1.3. Turkey

            18.4.1.4. Rest of Middle East and Africa

        18.4.2. By Route of Administration

        18.4.3. By Technology

        18.4.4. By Type

        18.4.5. By Disease Indication

        18.4.6. By End-user

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Route of Administration

        18.5.3. By Technology

        18.5.4. By Type

        18.5.5. By Disease Indication

        18.5.6. By End-user

19. Key Countries Vaccines Market Analysis 2015-2021 and Forecast 2022-2032

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. US Vaccines Market Analysis

        19.2.1. Value Proportion Analysis by Market Taxonomy

        19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.2.2.1. By Route of Administration

            19.2.2.2. By Technology

            19.2.2.3. By Type

            19.2.2.4. By Disease Indication

            19.2.2.5. By End-user

    19.3. Canada Vaccines Market Analysis

        19.3.1. Value Proportion Analysis by Market Taxonomy

        19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.3.2.1. By Route of Administration

            19.3.2.2. By Technology

            19.3.2.3. By Type

            19.3.2.4. By Disease Indication

            19.3.2.5. By End-user

    19.4. Mexico Vaccines Market Analysis

        19.4.1. Value Proportion Analysis by Market Taxonomy

        19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.4.2.1. By Route of Administration

            19.4.2.2. By Technology

            19.4.2.3. By Type

            19.4.2.4. By Disease Indication

            19.4.2.5. By End-user

    19.5. Brazil Vaccines Market Analysis

        19.5.1. Value Proportion Analysis by Market Taxonomy

        19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.5.2.1. By Route of Administration

            19.5.2.2. By Technology

            19.5.2.3. By Type

            19.5.2.4. By Disease Indication

            19.5.2.5. By End-user

    19.6. Germany Vaccines Market Analysis

        19.6.1. Value Proportion Analysis by Market Taxonomy

        19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.6.2.1. By Route of Administration

            19.6.2.2. By Technology

            19.6.2.3. By Type

            19.6.2.4. By Disease Indication

            19.6.2.5. By End-user

    19.7. France Vaccines Market Analysis

        19.7.1. Value Proportion Analysis by Market Taxonomy

        19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.7.2.1. By Route of Administration

            19.7.2.2. By Technology

            19.7.2.3. By Type

            19.7.2.4. By Disease Indication

            19.7.2.5. By End-user

    19.8. Italy Vaccines Market Analysis

        19.8.1. Value Proportion Analysis by Market Taxonomy

        19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.8.2.1. By Route of Administration

            19.8.2.2. By Technology

            19.8.2.3. By Type

            19.8.2.4. By Disease Indication

            19.8.2.5. By End-user

    19.9. Russia Vaccines Market Analysis

        19.9.1. Value Proportion Analysis by Market Taxonomy

        19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.9.2.1. By Route of Administration

            19.9.2.2. By Technology

            19.9.2.3. By Type

            19.9.2.4. By Disease Indication

            19.9.2.5. By End-user

    19.10. UK Vaccines Market Analysis

        19.10.1. Value Proportion Analysis by Market Taxonomy

        19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.10.2.1. By Route of Administration

            19.10.2.2. By Technology

            19.10.2.3. By Type

            19.10.2.4. By Disease Indication

            19.10.2.5. By End-user

    19.11. China Vaccines Market Analysis

        19.11.1. Value Proportion Analysis by Market Taxonomy

        19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.11.2.1. By Route of Administration

            19.11.2.2. By Technology

            19.11.2.3. By Type

            19.11.2.4. By Disease Indication

            19.11.2.5. By End-user

    19.12. Japan Vaccines Market Analysis

        19.12.1. Value Proportion Analysis by Market Taxonomy

        19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.12.2.1. By Route of Administration

            19.12.2.2. By Technology

            19.12.2.3. By Type

            19.12.2.4. By Disease Indication

            19.12.2.5. By End-user

    19.13. South Korea Vaccines Market Analysis

        19.13.1. Value Proportion Analysis by Market Taxonomy

        19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.13.2.1. By Route of Administration

            19.13.2.2. By Technology

            19.13.2.3. By Type

            19.13.2.4. By Disease Indication

            19.13.2.5. By End-user

    19.14. GCC Countries Vaccines Market Analysis

        19.14.1. Value Proportion Analysis by Market Taxonomy

        19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.14.2.1. By Route of Administration

            19.14.2.2. By Technology

            19.14.2.3. By Type

            19.14.2.4. By Disease Indication

            19.14.2.5. By End-user

    19.15. South Africa Vaccines Market Analysis

        19.15.1. Value Proportion Analysis by Market Taxonomy

        19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.15.2.1. By Route of Administration

            19.15.2.2. By Technology

            19.15.2.3. By Type

            19.15.2.4. By Disease Indication

            19.15.2.5. By End-user

    19.16. Turkey Vaccines Market Analysis

        19.16.1. Value Proportion Analysis by Market Taxonomy

        19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.16.2.1. By Route of Administration

            19.16.2.2. By Technology

            19.16.2.3. By Type

            19.16.2.4. By Disease Indication

            19.16.2.5. By End-user

        19.16.3. Competition Landscape and Player Concentration in the Country

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies 

    20.2. Market Concentration

    20.3. Market Share Analysis of Top Players

    20.4. Market Presence Analysis

        20.4.1. By Regional footprint of Players

        20.4.2. Product footprint by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive 

        21.3.1. GlaxoSmithKline plc

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Sales Footprint

            21.3.1.4. Strategy Overview

        21.3.2. Merck & Co., Inc.

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Sales Footprint

            21.3.2.4. Strategy Overview

        21.3.3. Pfizer

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Sales Footprint

            21.3.3.4. Strategy Overview

        21.3.4. Sanofi SA

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Sales Footprint

            21.3.4.4. Strategy Overview

        21.3.5. CSL Limited

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Sales Footprint

            21.3.5.4. Strategy Overview

        21.3.6. Emergent BioSolutions Inc.

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Sales Footprint

            21.3.6.4. Strategy Overview

        21.3.7. Johnson & Johnson (J&J)

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Sales Footprint

            21.3.7.4. Strategy Overview

        21.3.8. AstraZeneca

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Sales Footprint

            21.3.8.4. Strategy Overview

        21.3.9. Bavarian Nordic A/S

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Sales Footprint

            21.3.9.4. Strategy Overview

        21.3.10. Mitsubishi Tanabe Pharma Corporation

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Sales Footprint

            21.3.10.4. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 2: Global Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 3: Global Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021

Table 4: Global Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032

Table 5: Global Vaccines Market Value (US$ Mn), By Type, 2015 – 2021

Table 6: Global Vaccines Market Value (US$ Mn), By Type, 2022 – 2032

Table 7: Global Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021

Table 8: Global Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032

Table 9: Global Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 10: Global Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 11: Global Vaccines Market, By Region, 2015 – 2021

Table 12: Global Vaccines Market, By Region, 2022 – 2032

Table 13: North America Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 14: North America Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 15: North America Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021

Table 16: North America Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032

Table 17: North America Vaccines Market Value (US$ Mn), By Type, 2015 – 2021

Table 18: North America Vaccines Market Value (US$ Mn), By Type, 2022 – 2032

Table 19: North America Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021

Table 20: North America Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032

Table 21: North America Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 22: North America Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 23: North America Vaccines Market, By Country, 2015 – 2021

Table 24: North America Vaccines Market, By Country, 2022 – 2032

Table 25: Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 26: Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 27: Latin America Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021

Table 28: Latin America Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032

Table 29: Latin America Vaccines Market Value (US$ Mn), By Type, 2015 – 2021

Table 30: Latin America Vaccines Market Value (US$ Mn), By Type, 2022 – 2032

Table 31: Latin America Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021

Table 32: Latin America Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032

Table 33: Latin America Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 34: Latin America Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 35: Latin America Vaccines Market, By Country, 2015 – 2021

Table 36: Latin America Vaccines Market, By Country, 2022 – 2032

Table 37: Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 38: Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 39: Europe Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021

Table 40: Europe Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032

Table 41: Europe Vaccines Market Value (US$ Mn), By Type, 2015 – 2021

Table 42: Europe Vaccines Market Value (US$ Mn), By Type, 2022 – 2032

Table 43: Europe Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021

Table 44: Europe Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032

Table 45: Europe Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 46: Europe Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 47: Europe Vaccines Market, By Country, 2015 – 2021

Table 48: Europe Vaccines Market, By Country, 2022 – 2032

Table 49: Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 50: Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 51: Asia Pacific Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021

Table 52: Asia Pacific Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032

Table 53: Asia Pacific Vaccines Market Value (US$ Mn), By Type, 2015 – 2021

Table 54: Asia Pacific Vaccines Market Value (US$ Mn), By Type, 2022 – 2032

Table 55: Asia Pacific Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021

Table 56: Asia Pacific Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032

Table 57: Asia Pacific Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 58: Asia Pacific Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 59: Asia Pacific Vaccines Market, By Country, 2015 – 2021

Table 60: Asia Pacific Vaccines Market, By Country, 2022 – 2032

Table 61: MEA Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 62: MEA Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 63: MEA Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021

Table 64: MEA Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032

Table 65: MEA Vaccines Market Value (US$ Mn), By Type, 2015 – 2021

Table 66: MEA Vaccines Market Value (US$ Mn), By Type, 2022 – 2032

Table 67: MEA Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021

Table 68: MEA Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032

Table 69: MEA Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 70: MEA Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 71: MEA Vaccines Market, By Country, 2015 – 2021

Table 72: MEA Vaccines Market, By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Vaccines Market Share, By Route of Administration, 2022 & 2032

Figure 4: Global Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 5: Global Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 6: Global Vaccines Market Share, By Technology, 2022 & 2032

Figure 7: Global Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 8: Global Vaccines Market Attractiveness Index, By Technology – 2022-2032

Figure 9: Global Vaccines Market Share, By End-user, 2022 & 2032

Figure 10: Global Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032

Figure 11: Global Vaccines Market Attractiveness Index, By End-user – 2022-2032

Figure 12: Global Vaccines Market Share, By Type, 2022 & 2032

Figure 13: Global Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 14: Global Vaccines Market Attractiveness Index, By Type – 2022-2032

Figure 15: Global Vaccines Market Share, By Disease Indication, 2022 & 2032

Figure 16: Global Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 17: Global Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 18: Global Vaccines Market Share, By Region, 2022 & 2032

Figure 19: Global Vaccines Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 20: Global Vaccines Market Attractiveness Index, By Region – 2022-2032

Figure 21: North America Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 22: North America Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 23: North America Vaccines Market Share, By Route of Administration, 2022 & 2032

Figure 24: North America Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 25: North America Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 26: North America Vaccines Market Share, By Technology, 2022 & 2032

Figure 27: North America Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 28: North America Vaccines Market Attractiveness Index, By Technology – 2022-2032

Figure 29: North America Vaccines Market Share, By End-user, 2022 & 2032

Figure 30: North America Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032

Figure 31: North America Vaccines Market Attractiveness Index, By End-user – 2022-2032

Figure 32: North America Vaccines Market Share, By Type, 2022 & 2032

Figure 33: North America Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 34: North America Vaccines Market Attractiveness Index, By Type – 2022-2032

Figure 35: North America Vaccines Market Share, By Disease Indication, 2022 & 2032

Figure 36: North America Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 37: North America Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 38: North America Vaccines Market Share, By Country, 2022 & 2032

Figure 39: North America Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 40: North America Vaccines Market Attractiveness Index, By Country – 2022-2032

Figure 41: Latin America Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 42: Latin America Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 43: Latin America Vaccines Market Share, By Route of Administration, 2022 & 2032

Figure 44: Latin America Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 45: Latin America Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 46: Latin America Vaccines Market Share, By Technology, 2022 & 2032

Figure 47: Latin America Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 48: Latin America Vaccines Market Attractiveness Index, By Technology – 2022-2032

Figure 49: Latin America Vaccines Market Share, By End-user, 2022 & 2032

Figure 50: Latin America Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032

Figure 51: Latin America Vaccines Market Attractiveness Index, By End-user – 2022-2032

Figure 52: Latin America Vaccines Market Share, By Type, 2022 & 2032

Figure 53: Latin America Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 54: Latin America Vaccines Market Attractiveness Index, By Type – 2022-2032

Figure 55: Latin America Vaccines Market Share, By Disease Indication, 2022 & 2032

Figure 56: Latin America Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 57: Latin America Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 58: Latin America Vaccines Market Share, By Country, 2022 & 2032

Figure 59: Latin America Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 60: Latin America Vaccines Market Attractiveness Index, By Country – 2022-2032

Figure 61: Europe Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 62: Europe Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 63: Europe Vaccines Market Share, By Route of Administration, 2022 & 2032

Figure 64: Europe Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 65: Europe Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 66: Europe Vaccines Market Share, By Technology, 2022 & 2032

Figure 67: Europe Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 68: Europe Vaccines Market Attractiveness Index, By Technology – 2022-2032

Figure 69: Europe Vaccines Market Share, By End-user, 2022 & 2032

Figure 70: Europe Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032

Figure 71: Europe Vaccines Market Attractiveness Index, By End-user – 2022-2032

Figure 72: Europe Vaccines Market Share, By Type, 2022 & 2032

Figure 73: Europe Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 74: Europe Vaccines Market Attractiveness Index, By Type – 2022-2032

Figure 75: Europe Vaccines Market Share, By Disease Indication, 2022 & 2032

Figure 76: Europe Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 77: Europe Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 78: Europe Vaccines Market Share, By Country, 2022 & 2032

Figure 79: Europe Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 80: Europe Vaccines Market Attractiveness Index, By Country – 2022-2032

Figure 81: Asia Pacific Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 82: Asia Pacific Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 83: Asia Pacific Vaccines Market Share, By Route of Administration, 2022 & 2032

Figure 84: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 85: Asia Pacific Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 86: Asia Pacific Vaccines Market Share, By Technology, 2022 & 2032

Figure 87: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 88: Asia Pacific Vaccines Market Attractiveness Index, By Technology – 2022-2032

Figure 89: Asia Pacific Vaccines Market Share, By End-user, 2022 & 2032

Figure 90: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032

Figure 91: Asia Pacific Vaccines Market Attractiveness Index, By End-user – 2022-2032

Figure 92: Asia Pacific Vaccines Market Share, By Type, 2022 & 2032

Figure 93: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 94: Asia Pacific Vaccines Market Attractiveness Index, By Type – 2022-2032

Figure 95: Asia Pacific Vaccines Market Share, By Disease Indication, 2022 & 2032

Figure 96: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 97: Asia Pacific Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 98: Asia Pacific Vaccines Market Share, By Country, 2022 & 2032

Figure 99: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 100: Asia Pacific Vaccines Market Attractiveness Index, By Country – 2022-2032

Figure 101: MEA Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 102: MEA Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 103: MEA Vaccines Market Share, By Route of Administration, 2022 & 2032

Figure 104: MEA Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 105: MEA Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 106: MEA Vaccines Market Share, By Technology, 2022 & 2032

Figure 107: MEA Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 108: MEA Vaccines Market Attractiveness Index, By Technology – 2022-2032

Figure 109: MEA Vaccines Market Share, By End-user, 2022 & 2032

Figure 110: MEA Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032

Figure 111: MEA Vaccines Market Attractiveness Index, By End-user – 2022-2032

Figure 112: MEA Vaccines Market Share, By Type, 2022 & 2032

Figure 113: MEA Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032

Figure 114: MEA Vaccines Market Attractiveness Index, By Type – 2022-2032

Figure 115: MEA Vaccines Market Share, By Disease Indication, 2022 & 2032

Figure 116: MEA Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 117: MEA Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 118: MEA Vaccines Market Share, By Country, 2022 & 2032

Figure 119: MEA Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 120: MEA Vaccines Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate